Publication | Closed Access

Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression

Tumor BiologyOncologyOncogenic AgentMedicineCisplatin-induced CytotoxicityPharmacologyAnti-cancer AgentTumor SuppressorCancer BiologyCell BiologyLung CancerCancer Research